Research on Pharmaceutics Reported by a Researcher at Jinan University (From Tyrosine Kinases to Tyrosine Phosphatases: New Therapeutic Targets in Cancers and Beyond).

A report from Jinan University discusses the role of protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs) in regulating tyrosine phosphorylation in proteins. PTKs were once considered promising targets for cancer therapy, but face challenges such as drug resistance and side effects. The report highlights the potential of PTPs as viable therapeutic targets and discusses strategies and prospects for PTP-targeted therapy. The research suggests that with advances in allosteric inhibition and alternative drug strategies, PTPs are now considered "druggable" targets. [Extracted from the article]